Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Acceleron Pharma Inc."
Count: 33
Selected: 0
| NCT ID | Title |
|---|
| NCT04948554 | A Study of MK-2225 / ACE-1334 in Participants With Systemic Sclerosis With and Without Interstitial Lung Disease (MK-2225-002) | ||
| NCT04945460 | A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16) | ||
| NCT04896008 | A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH) | ||
| NCT04811092 | Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants (MK-7962-005/A011-13) | ||
| NCT04796337 | A Long-term Follow-up Study of Sotatercept for PAH Treatment (MK-7962-004) | ||
| NCT04576988 | A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR) | ||
| NCT03496207 | A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH) | ||
| NCT03738150 | A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension | ||
| NCT01099761 | Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy | ||
| NCT01727336 | Study of Dalantercept and Axitinib in Patients With Advanced Renal Cell Carcinoma | ||
| NCT01458392 | Study of Dalantercept in Patients With Squamous Cell Carcinoma of the Head and Neck | ||
| NCT03943290 | Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Charcot-Marie Tooth (CMT) Disease Types 1 and X (CMT1 and CMTX) | ||
| NCT03124459 | Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease | ||
| NCT02927080 | Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) | ||
| NCT02024087 | Study of Dalantercept and Sorafenib in Patients With Advanced Hepatocellular Carcinoma | ||
| NCT02257489 | Phase 1 Study of ACE-083 in Healthy Subjects | ||
| NCT00709540 | A Safety, Tolerability and Pharmacodynamics Study of ACE-011 (ActRIIA-IgG1) in Healthy Postmenopausal Women | ||
| NCT02268409 | ACE-536 Extension Study - Beta Thalassemia | ||
| NCT02268383 | ACE-536 Extension Study - Myelodysplastic Syndromes | ||
| NCT01749514 | Study of ACE-536 for the Treatment of Anemia in Patients With Myelodysplastic Syndromes (MDS) | ||
| NCT03478319 | A Study of ACE-2494 in Healthy Subjects | ||
| NCT01749540 | Study to Evaluate the Effects of ACE-536 in Patients With Beta-thalassemia | ||
| NCT00996957 | Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma | ||
| NCT01239758 | Extension Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy | ||
| NCT01432717 | Study of ACE-536 in Healthy Postmenopausal Women | ||
| NCT00952887 | A Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ACE-031 in Healthy Postmenopausal Women | ||
| NCT00755638 | A Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ACE-031 (ActRIIB-IgG1)in Healthy Postmenopausal Volunteers | ||
| NCT03682536 | A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve | ||
| NCT02604433 | An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Cell Transfusions Due to Beta (β) Thalassemia | ||
| NCT04143724 | Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants Who Require Regular RBC Transfusions Due to Beta (β)-Thalassemia. | ||
| NCT03342404 | A Study to Determine the Efficacy and Safety of Luspatercept in Adults With Non Transfusion Dependent Beta (β)-Thalassemia | ||
| NCT02631070 | A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes | ||
| NCT01146574 | A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis. |
